Axim Biotechnologies Inc (QB) (AXIM) Fundamentals

Description
Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axims core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays.
Share Info
StatusActive
Market Cap$ 8,485,743
Shares Authorized300,000,000
Shares Outstanding157,143,392
Shares Outstanding Date06/10/2022
Shareholder Count73
Shareholder Count Date04/15/2021
Float39,530,832
Float Date09/30/2021
Short Interest45,245
Short Interest Date05/31/2022
Reporting Info
Reporting StatusSEC Reporting
BankruptNo
ShellNo
Audit StatusYes
AuditorRBSM LLP
Auditor Address805 3rd Avenue,
Suite 143C
New York, New York 10022
USA
Auditor Websitehttp://www.rbsmllp.com
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselProcopio, Cory, Hargreaves & Savitch LLP.
Legal Counsel Address525 B Street, Suite 2200
San Diego, California 92101
USA
Legal Counsel Website-
Fiscal Year End12/31
ADR Ratio-
Transfer AgentAction Stock Transfer Corporation
Transfer Agent Address2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
USA
Depository Websitehttp://www.actionstocktransfer.com
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:AXIM
OTC Market TierOTCQB
Security TypeCommon Stock
CIK Number0001514946
Address6191 Cornerstone Court E.
Suite 114
San Diego, California 92121
CountryUSA
Phone(858) 923-4422
Fax #-
Websitehttp://www.aximbiotech.com
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesDir. - Blake Schroeder
Dir. - Blake Schroeder
Director, Audits - Timothy Scott
Director, Audits - Timothy Scott
Dir. - Robert Cunningham
Dir. - Robert Cunningham
CFO - Robert Malasek
CFO - Robert Malasek
Corporate Counsel - Phillip E Koehnke ESQ
Corporate Counsel - Phillip E Koehnke ESQ
Dir. - Peter O'Rourke
Dir. - Peter O'Rourke
CEO - John Huemoeller II
CEO - John Huemoeller II
Number of Employees8
Incorporation StateNevada
Incorporation CountryUSA
Incorporation Year2010


Your Recent History
USOTC
AXIM
Axim Biote..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.